Laura Zamorano - Concepedia

Author

Laura Zamorano

Hospital Universitario Son Espases ORCID

Also Known As

L Zamorano, L. Zamorano, Laura S. Zamorano, Laura Sánchez Zamorano, Laura Zamorano, María Antonia Gomis-Font

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Son Espases Health Research Institute of the Balearic Islands Research Institute of Health Sciences Instituto de Investigación Biomédica de A Coruña Hospital de Sant Pau

About

Laura Zamorano is an author at Hospital Universitario Son Espases specializing in medicine, clinical microbiology, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	22	1.7K
2	Health Sciences	13	13	1.3K
3	Biochemistry	7	7	319
4	Engineering	2	2	43
5	Biomolecular Engineering	1	1	23

Laura Zamorano

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
β-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein Bartolomé Moyá, Andreas Dötsch, Carlos Juan, PLoS Pathogens	2009	285
Pseudomonas aeruginosa Ceftolozane-Tazobactam Resistance Development Requires Multiple Mutations Leading to Overexpression and Structural Modification of AmpC Gabriel Cabot, Sebastian Bruchmann, Xavier Mulet, Antimicrobial Agents and Chemotherapy Molecular BiologyAntimicrobial ChemotherapyAntibiotic ResistanceBacterial PathogensDrug Resistance	2014	239
Influence of Virulence Genotype and Resistance Profile in the Mortality of Pseudomonas aeruginosa Bloodstream Infections Carmen Peña, Gabriel Cabot, Sílvia Gómez-Zorrilla, Clinical Infectious Diseases	2014	218
Overexpression of AmpC and Efflux Pumps in Pseudomonas aeruginosa Isolates from Bloodstream Infections: Prevalence and Impact on Resistance in a Spanish Multicenter Study Gabriel Cabot, Alain A. Ocampo-Sosa, Fé Tubau, Antimicrobial Agents and Chemotherapy Medical MicrobiologyAntimicrobial Resistance GenePseudomonas Aeruginosa IsolatesRepresentative IsolatesHealth Sciences	2011	214
Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates Gabriel Cabot, Laura Zamorano, Bartolomé Moyá, Antimicrobial Agents and Chemotherapy	2016	205
Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain Ester del Barrio-Tofiño, Carla López-Causapé, Gabriel Cabot, Antimicrobial Agents and Chemotherapy	2017	167
Prospective Multicenter Study of Carbapenemase-Producing Enterobacteriaceae from 83 Hospitals in Spain Reveals High <i>In Vitro</i> Susceptibility to Colistin and Meropenem Jesús Oteo, Adriana Ortega, Rosa Bartolomé, Antimicrobial Agents and Chemotherapy	2015	146
Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology Ester del Barrio-Tofiño, Laura Zamorano, Sara Cortés-Lara, Journal of Antimicrobial Chemotherapy	2019	144
Pan-β-Lactam Resistance Development in Pseudomonas aeruginosa Clinical Strains: Molecular Mechanisms, Penicillin-Binding Protein Profiles, and Binding Affinities Bartolomé Moyá, Alejandro Beceiro, Gabriel Cabot, Antimicrobial Agents and Chemotherapy Microbial PathogensAntibiotic ResistanceBacterial PathogensBinding AffinitiesDrug Resistance	2012	139
Biological Markers of Pseudomonas aeruginosa Epidemic High-Risk Clones Xavier Mulet, Gabriel Cabot, Alain A. Ocampo-Sosa, Antimicrobial Agents and Chemotherapy	2013	130

Page 1